Search

Your search keyword '"van Hoek, Bart"' showing total 752 results

Search Constraints

Start Over You searched for: Author "van Hoek, Bart" Remove constraint Author: "van Hoek, Bart"
752 results on '"van Hoek, Bart"'

Search Results

2. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial

3. OS-120 Fazirsiran reduces liver Z-alpha-1 antitrypsin synthesis, decreases globule burden and improves histological measures of liver disease in adults with alpha-1 antitrypsin deficiency: a randomized placebo-controlled phase 2 study

5. Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)

6. Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework

7. Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study

8. Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

9. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis

11. Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype)

12. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis

17. Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group

20. Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis

21. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation

24. A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation

25. Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial

27. THU-138 The male-to-female ratio among patients with primary biliary cholangitis depends on age

28. OS-015 Time to complete biochemical response and disease progression in autoimmune hepatitis

29. FRI-043 A multi-center randomized controlled study of primary prevention of esophageal variceal bleeding in cirrhotic patients treated with HVPG-guided therapy or standard heart rate-guided therapy: an interim analysis of the PORTHOS trial

30. Incidence and prevalence of primary biliary cholangitis in the Netherlands – a nationwide cohort study

31. WED-135-YI Impact of metabolic alterations on liver phenotype of patients with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ)

32. THU-100 Factors associated with the real-world biochemical response to fibrate therapy in primary biliary cholangitis

33. TOP-141 Longitudinal assessment of individuals with homozygous alpha-1 antitrypsin deficiency (Pi*ZZ genotype) provides evidence for clinical patient management

34. THU-120-YI The impact of ursodeoxycholic acid on biochemistry of patients with primary biliary cholangitis in a nationwide cohort

36. SAT-021 Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival in an international multicentre cohort

42. Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 Months

45. Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patients

47. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial

48. Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

49. Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study

50. Modifying Tacrolimus-related Toxicity After Liver Transplantation Comparing Life Cycle Pharma Tacrolimus Versus Extended-released Tacrolimus:A Multicenter, Randomized Controlled Trial

Catalog

Books, media, physical & digital resources